NJ Robert

Statistics

Publications

Citations

273

H-Index

Active since

1983

Affiliations

MedStar Washington Hospital Center(Current)

NJ Robert is an author at MedStar Washington Hospital Center specializing in oncology, her2-positive breast cancer therapy, and her2-positive breast cancer immunotherapy.

Publications per year

1983–2016

Publications

Abstract S5-04: Ten year follow-up of BCIRG-006 comparing doxorubicin plus cyclophosphamide followed by docetaxel (AC→T) with doxorubicin plus cyclophosphamide followed by docetaxel and trastuzumab (AC→TH) with docetaxel, carboplatin and trastuzumab (TCH) in HER2+ early breast cancer

DJ Slamon, W. Eiermann, NJ Robert et al. · Cancer Research · 2016 · 149 citations

Medicine, Oncology, Pharmacology +17

Abstract S1-03: Primary results from BETH, a phase 3 controlled study of adjuvant chemotherapy and trastuzumab ± bevacizumab in patients with HER2-positive, node-positive or high risk node-negative breast cancer

DJ Slamon, SM Swain, Marc Buyse et al. · Cancer Research · 2013 · 92 citations

Medicine, Oncology, Pharmacology +17

In Waldenstrom's macroglobulinemia the quantity of detectable circulating monoclonal B lymphocytes correlates with clinical course

BR Smith, NJ Robert, KA Ault · Blood · 1983 · 32 citations · Full text

Life Sciences, Hematology, Immunology +10

1–3 of 3